Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
INFU 
InfuSystems Holdings Inc (INFU)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/02/2026: INFU (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $14.2
1 Year Target Price $14.2
| 4 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -31.88% | Avg. Invested days 34 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 01/02/2026 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 171.37M USD | Price to earnings Ratio 32.27 | 1Y Target Price 14.2 |
Price to earnings Ratio 32.27 | 1Y Target Price 14.2 | ||
Volume (30-day avg) 4 | Beta 1.71 | 52 Weeks Range 4.61 - 11.04 | Updated Date 01/3/2026 |
52 Weeks Range 4.61 - 11.04 | Updated Date 01/3/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.26 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.92% | Operating Margin (TTM) 10.44% |
Management Effectiveness
Return on Assets (TTM) 7.24% | Return on Equity (TTM) 9.96% |
Valuation
Trailing PE 32.27 | Forward PE 23.98 | Enterprise Value 194357575 | Price to Sales(TTM) 1.22 |
Enterprise Value 194357575 | Price to Sales(TTM) 1.22 | ||
Enterprise Value to Revenue 1.38 | Enterprise Value to EBITDA 8.05 | Shares Outstanding 20336183 | Shares Floating 19259179 |
Shares Outstanding 20336183 | Shares Floating 19259179 | ||
Percent Insiders 6.89 | Percent Institutions 75.73 |
Upturn AI SWOT
InfuSystems Holdings Inc
Company Overview
History and Background
InfuSystems Holdings Inc. (formerly known as InfuCare Health Systems) has a history primarily focused on providing home infusion therapy services. The company has undergone various stages of development and strategic shifts within the healthcare services sector. Specific founding year and detailed early milestones are not readily available in public summaries. Its evolution has likely involved adapting to changes in healthcare regulations, reimbursement policies, and advancements in medical technology for home-based patient care.
Core Business Areas
- Home Infusion Therapy Services: Providing specialized intravenous (IV) therapies and related services to patients in their homes. This includes clinical monitoring, medication administration, and patient education for conditions requiring long-term IV treatment.
- Durable Medical Equipment (DME) and Supplies: Supplying necessary medical equipment, such as infusion pumps, and related consumables required for home infusion therapy.
Leadership and Structure
Information on the specific current leadership team and detailed organizational structure of InfuSystems Holdings Inc. is not publicly detailed in readily accessible summaries. Like most public companies, it would typically have a Board of Directors, a CEO, and various departmental heads overseeing operations, finance, sales, and clinical services.
Top Products and Market Share
Key Offerings
- Home Infusion Therapy Services: [object Object]
- Infusion Pumps and Supplies: [object Object]
Market Dynamics
Industry Overview
The home infusion therapy market is a growing segment within the broader healthcare industry, driven by an aging population, increasing prevalence of chronic diseases, and a preference for home-based care over hospitalizations due to cost-effectiveness and patient comfort. Regulatory changes and reimbursement policies from Medicare and private insurers significantly impact the industry.
Positioning
InfuSystems Holdings Inc. operates in the home infusion therapy sector, aiming to provide essential clinical services and medical supplies to patients at home. Its competitive advantage would lie in its clinical expertise, established patient referral networks, and efficient operational logistics for service delivery.
Total Addressable Market (TAM)
The total addressable market for home infusion therapy in the United States is substantial and growing, estimated to be tens of billions of dollars annually. InfuSystems Holdings Inc. targets a specific portion of this TAM based on its service offerings and geographic reach. Its positioning relative to the TAM is as a provider of these services, aiming to capture market share through its clinical capabilities and operational efficiency.
Upturn SWOT Analysis
Strengths
- Specialized clinical expertise in home infusion therapy.
- Potential for cost savings for patients and payers compared to inpatient care.
- Focus on patient convenience and comfort.
- Established relationships with healthcare providers for referrals.
Weaknesses
- Dependence on reimbursement rates from government and private payers.
- Potential challenges in recruiting and retaining qualified clinical staff.
- Competition from larger, well-established national players.
- Operational complexity in managing logistics for home-based services.
Opportunities
- Increasing demand for home-based healthcare services.
- Expansion into new therapeutic areas or geographic regions.
- Technological advancements in infusion delivery and remote patient monitoring.
- Partnerships with hospitals and health systems to facilitate patient discharge.
Threats
- Changes in healthcare regulations and reimbursement policies.
- Increased competition leading to price pressures.
- Emergence of alternative treatment modalities that reduce the need for infusion therapy.
- Economic downturns impacting healthcare spending.
Competitors and Market Share
Key Competitors
- Option Care Health (OPCH)
- Coram Healthcare (part of CVS Health)
- Omnicare (part of CVS Health)
Competitive Landscape
InfuSystems Holdings Inc. faces a competitive landscape dominated by larger, national players with significant resources and established referral networks. Its advantages could be found in its agility, specialized clinical focus, and potentially more personalized service delivery. Disadvantages might include limited market reach and brand recognition compared to larger competitors.
Growth Trajectory and Initiatives
Historical Growth: The historical growth trajectory of InfuSystems Holdings Inc. has likely been influenced by market demand for home infusion services and strategic business decisions. Past performance would need to be reviewed to identify periods of significant expansion or contraction.
Future Projections: Specific future growth projections for InfuSystems Holdings Inc. from analyst estimates are not widely published. However, the overall home infusion therapy market is generally projected to grow, driven by demographic trends and healthcare preferences. The company's future growth will depend on its ability to capture market share, expand its service offerings, and adapt to regulatory and economic changes.
Recent Initiatives: Recent strategic initiatives for InfuSystems Holdings Inc. are not detailed in readily available public summaries. Such initiatives could include expanding service lines, entering new geographic markets, improving operational efficiency, or pursuing strategic partnerships and acquisitions.
Summary
InfuSystems Holdings Inc. operates in the growing home infusion therapy market, a sector favored for its patient convenience and cost-effectiveness. The company's strengths lie in its clinical expertise and focus on home-based care. However, it faces significant challenges from larger competitors, dependence on payer reimbursements, and the need to recruit and retain skilled clinical staff. Its future success hinges on navigating a complex regulatory environment and capitalizing on the increasing demand for home healthcare services.
Similar Stocks
Sources and Disclaimers
Data Sources:
- General industry reports and analyses.
- Company press releases (where available).
- Financial news outlets.
Disclaimers:
This information is compiled from publicly available sources and general market knowledge. It is not intended as investment advice. Specific financial data and market share figures for InfuSystems Holdings Inc. may be limited or not current. Investors should conduct their own due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About InfuSystems Holdings Inc
Exchange NYSE MKT | Headquaters Rochester Hills, MI, United States | ||
IPO Launch date 2007-12-27 | President, CEO & Director Ms. Carrie A. Lachance B.S.N., M.B.A., R.N. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 502 | Website https://www.infusystem.com |
Full time employees 502 | Website https://www.infusystem.com | ||
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates in two segments, Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.